Stock market guru, SP Tulsian, on Friday said he continued to maintain positive view on Biocon, Aurobindo Pharma, Divis Lab and Sun Pharma.
Tulsian said state-owned Oil India Ltd is always been a laggard, "The company is just one tenth of ONGC in terms of turnover, production, volume and profitability ballpark."
"If ONGC corrects by 3-4 percent, Oil India has to take a hit by about 5-6 percent as profitability impact would be higher in case of Oil India than ONGC. Upstream companies will be having the negative bias because of crude softness," Tulsian said.
Further, he said IT and pharma are the two sectors which got corrected.
The views and investment tips expressed by investment experts on CNBCTV18.com are their own and not that of the website or its management. CNBCTV18.com advises users to check with certified experts before taking any investment decisions.